Brain+ A/S (CPH:BRAINP)
Denmark · Delayed Price · Currency is DKK 0.0158
+0.0008 (5.33%)
Jul 25, 2025, 1:49 PM CET
Brain+ Market Cap
Brain+ has a market cap or net worth of 17.90 million as of July 25, 2025. Its market cap has decreased by -14.45% in one year.
Market Cap
17.90M
Enterprise Value
17.84M
Revenue
7.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since October 7, 2021, Brain+'s market cap has decreased from 51.99M to 17.90M, a decrease of -65.57%. That is a compound annual growth rate of -24.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 17.90M | -10.21% |
| Dec 30, 2024 | 19.94M | 56.98% |
| Dec 29, 2023 | 12.70M | -37.15% |
| Dec 30, 2022 | 20.21M | -50.00% |
| Dec 30, 2021 | 40.41M | -22.27% |
| Oct 7, 2021 | 51.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 2,006.90B |
| Coloplast | 139.24B |
| Genmab | 91.67B |
| Demant | 59.60B |
| ALK-Abelló | 43.68B |
| H. Lundbeck | 33.89B |
| Ambu A/S | 27.04B |
| Zealand Pharma | 26.60B |